Morgan Stanley downgraded Medacta Group to Equal Weight from Overweight with a price target of CHF 113, up from CHF 106. The analyst cites valuation for the downgrade with the shares up over 50% since October.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>